All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome

• Material Type: 記事
• Title: All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome
• Author/Editor: Mana Kobayashi; Yutaro Kageyama; Takashi Ando
• Publication, Distribution, etc.: 日本 : Springer Nature
• Publication Date: 2021-04-01
• Publication Date (W3CDTF): 2021-04-01
• Periodical title: Clinical and experimental nephrology : official publication of the Japanese Society of Nephrology
• No. or year of volume/issue: 25(8)
• Volume: 25(8)
• ISSN (Periodical Title): 1437-7799
• ISSN-L (Periodical Title): 1437-7799
• Text Language Code: eng
• DOI: 10.1007/s10157-021-02035-6; https://doi.org/10.1007/s10157-021-02035-6
• Persistent ID (NDL): info:ndljp/pid/11851796; https://dl.ndl.go.jp/pid/11851796
• Collection: 障害者向け資料
• Collection (Materials For Handicapped People:1): テキストデータ
• Collection (particular): 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他; https://dl.ndl.go.jp/collections/B00035
• Acquisition Basis: オンライン資料収集制度
• Date Accepted (W3CDTF): 2021-10-28T02:09:55+09:00
• Date Captured (W3CDTF): 2021-09-30
• Format (IMT): application/pdf
• Access Restrictions: 国立国会図書館内限定公開
• Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
• Availability of remote photoduplication service: 可
• Periodical Title (URI): https://link.springer.com/article/10.1007/s10157-021-02035-6
• Periodical Title (Persistent ID (NDL)): info:ndljp/pid/11851791; https://dl.ndl.go.jp/pid/11851791
• Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション; https://dl.ndl.go.jp

• Summary, etc.: コレクション : 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
• DOI: 10.1007/s10157-021-02035-6; https://doi.org/10.1007/s10157-021-02035-6
• Related Material (URI): http://id.ndl.go.jp/digimeta/11851796; https://dl.ndl.go.jp/pid/11851796; https://link.springer.com/content/pdf/10.1007/s10157-021-02035-6.pdf; https://link.springer.com/article/10.1007/s10157-021-02035-6/fulltext.html
• Is Referenced By: Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial); https://cir.nii.ac.jp/crid/1050299362553883136; Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists; https://cir.nii.ac.jp/crid/1360302864776687744; Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists; https://cir.nii.ac.jp/crid/1360584340696881664; Persistent SARS-CoV-2 Infection in a Patient with Nephrotic Syndrome under Rituximab Therapy: Successful Treatment with a Combination of Remdesivir and Monoclonal Antibodies; https://cir.nii.ac.jp/crid/1390575904638847872
• Data Provider (Database): 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• Original Data Provider (Database): 雑誌記事索引データベース; https://ndlsearch.ndl.go.jp; Crossref; https://www.crossref.org
• Bibliographic ID (NDL): 11851796; http://id.ndl.go.jp/bib/11851796